Cargando…

Current Status of Low-Density Lipoprotein Cholesterol and Cardiovascular Diseases in Japan

Detalles Bibliográficos
Autores principales:	Sun, Wanlu, Yamagishi, Kazumasa, Iso, Hiroyasu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164601/ https://www.ncbi.nlm.nih.gov/pubmed/36261367 http://dx.doi.org/10.5551/jat.ED217

Ejemplares similares

Non-High-Density Lipoprotein Cholesterol and Risk of Stroke Subtypes and Coronary Heart Disease: The Japan Public Health Center-Based Prospective (JPHC) Study
por: Saito, Isao, et al.
Publicado: (2020)

Soluble Vascular Cell Adhesion Molecule and Cardiovascular Disease: An Epidemiological View
por: Yamagishi, Kazumasa, et al.
Publicado: (2017)

Adiposity and risk of cardiovascular diseases in Japan: secular trend, individual level associations and causal pathway – implications for the prevention of cardiovascular diseases in societies with rapid economic development
por: Yatsuya, Hiroshi, et al.
Publicado: (2011)

The criteria for metabolic syndrome and the national health screening and education system in Japan
por: Yamagishi, Kazumasa, et al.
Publicado: (2017)

Of statins and low-density lipoprotein cholesterol, “fats” and fiction
por: Unnikrishnan, Ambika Gopalakrishnan, et al.
Publicado: (2016)

Low high-density lipoprotein cholesterol: current status and future strategies for management
por: Singh, Vibhuti, et al.
Publicado: (2010)

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
por: Willeit, Peter, et al.
Publicado: (2020)

Low‐density lipoprotein cholesterol and stroke: How low should we go?
por: Lui, David TW, et al.
Publicado: (2020)

Knowledge Gap Regarding Low Density Lipoprotein-Cholesterol Levels in Koreans
por: Kim, Hyeon Chang
Publicado: (2012)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
por: Sniderman, Allan D., et al.
Publicado: (2016)

Low-density lipoprotein cholesterol lowering treatment: the current approach
por: Crismaru, Irina, et al.
Publicado: (2020)

Possible Regulation of Platelets by Native and Modified Low Density Lipoprotein-Cholesterol Particles
por: Han, Ki Hoon
Publicado: (2012)

Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low‐Density Lipoprotein Cholesterol
por: Lawler, Patrick R., et al.
Publicado: (2017)

Low‐Density Lipoprotein Cholesterol Attributable Cardiovascular Disease Risk Is Sex Specific
por: Cupido, Arjen J., et al.
Publicado: (2022)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Is Non-High-Density Lipoprotein Cholesterol Evaluation Perfect? From the High-Density Lipoprotein Function Viewpoint
por: Otsuka, Toshiaki
Publicado: (2022)

Relationships between Age at Menarche and Risk of Cardiovascular Disease Mortality among Japanese Women: The Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC) Study
por: Ota, Kanako, et al.
Publicado: (2023)

High-Density Lipoproteins in Non-Cardiovascular Diseases
por: Zanotti, Ilaria
Publicado: (2022)

Personalized Medicine beyond Low-Density Lipoprotein Cholesterol to Combat Residual Risk for Coronary Artery Disease
por: Tada, Hayato
Publicado: (2021)

Low Density Lipoprotein Cholesterol Target Goal Attainment Rate in Korean Patients with Diabetes
por: Lee, Eun Hae, et al.
Publicado: (2011)

Dietary Patterns and Cardiovascular Disease Risk in Asia
por: Iso, Hiroyasu
Publicado: (2023)

Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges
por: Packard, Chris, et al.
Publicado: (2021)

Low-density lipoprotein cholesterol lowering therapy for the secondary prevention of atherosclerotic cardiovascular disease
por: Patel, Parth N., et al.
Publicado: (2020)

Coffee and Green Tea Consumption and Cardiovascular Disease Mortality Among People With and Without Hypertension
por: Teramoto, Masayuki, et al.
Publicado: (2022)

The Ratio of Triglyceride to High-density Lipoprotein Cholesterol as an Indicator of Risk Stratification for Atherosclerotic Cardiovascular Disease in a Clinical Setting
por: Tani, Shigemasa
Publicado: (2020)

Association of the Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio with Glecaprevir-pibrentasvir Treatment
por: Akutsu, Noriyuki, et al.
Publicado: (2021)

Clinical characteristics of cardiovascular patients with extremely low levels of high-density lipoprotein cholesterol
por: Sun, Lufan, et al.
Publicado: (2021)

Small-Dense Low-Density Lipoprotein Cholesterol: A Subclinical Marker for the Primary Prevention of Coronary Heart Disease
por: Kokubo, Yoshihiro, et al.
Publicado: (2020)

Impact of Body Mass Index on Obesity-Related Cancer and Cardiovascular Disease Mortality; The Japan Collaborative Cohort Study
por: Matsunaga, Masaaki, et al.
Publicado: (2022)

Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease: The Japan Epidemiology Collaboration on Occupational Health Study
por: Hu, Huan, et al.
Publicado: (2022)

Promoting predictive, preventive and personalized medicine in treatment of cardiovascular diseases
por: Iso, Hiroyasu
Publicado: (2011)

Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol
por: Zheng, Weili, et al.
Publicado: (2022)

Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk
por: Glavinovic, Tamara, et al.
Publicado: (2022)

Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density lipoprotein-high participants
por: Kim, Hye Jun, et al.
Publicado: (2023)

Small Dense Low-Density Lipoprotein Cholesterol and Cardiovascular Risk in Statin-Treated Patients with Coronary Artery Disease
por: Ishii, Junnichi, et al.
Publicado: (2022)

Assessment of serum levels of triglycerides, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol in periodontitis patients
por: Penumarthy, Swati, et al.
Publicado: (2013)

Self-reported eating habits and dyslipidemia in men aged 20–39 years: the Japan Environment and Children’s Study
por: Cui, Meishan, et al.
Publicado: (2023)

Urinary 8-Hydroxy-2′-Deoxyguanosine Levels and Cardiovascular Disease Incidence in Japan
por: Nagao, Masanori, et al.
Publicado: (2020)

Low Density Lipoprotein-Cholesterol/High Density Lipoprotein-Cholesterol Ratio Predicts Plaque Vulnerability in Patients With Stable Angina
por: Kim, Jeong Hun, et al.
Publicado: (2012)

Comparison of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol for the prediction of thin-cap fibroatheroma determined by intravascular optical coherence tomography
por: WANG, Yao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2dg3g7b51ufbdp9nhn6r7qds8u